1. Clinical & Scientific Overview
Adapalene 0.1% Gel, Benzoyl Peroxide 2.5%–5% Gel & Luliconazole 1% (TIP-MED-000425, Reference Code [12.6]-CMP155) is classified under
Dermatological & Topical Antiseptic Preparations (Ch 12) as a Topical Corticosteroids (Grouped by Potency: Super-Potent Clobetasol, Potent Mometasone/Betamethasone, Mild Hydrocortisone), Topical Imidazole/Allylamine Antifungals (Luliconazole, Clotrimazole, Sertaconazole, Terbinafine, Ketoconazole), Topical Antibacterials (Mupirocin, Fusidic Acid), and Ectoparasiticides (Permethrin 5%).
Within the Indian regulatory and compendial framework, it is governed under Schedule H Prescription Drug (To be sold by retail on the prescription of a Registered Medical Practitioner only — Drugs Rules 1945).
Co-indexed per approved Author Decisions DEC-03 (3A; from displaced HTML [12.27] & Inventory CSV mono-14-11) and DEC-12 (12A; from HTML [12.24]). Topical acne retinoid/peroxide and imidazole antifungals.
Standard approved strengths (refer to comparative context)
3. Mechanism of Action & Pharmacodynamics
Co-indexed per approved Author Decisions DEC-03 (3A; from displaced HTML [12.27] & Inventory CSV mono-14-11) and DEC-12 (12A; from HTML [12.24]). Topical acne retinoid/peroxide and imidazole antifungals.
4. Therapeutic Indications & Evidence-Supported Uses
- • Topical Corticosteroids: Eczema / atopic dermatitis, contact dermatitis, plaque psoriasis, lichen planus, seborrhoeic dermatitis
- • Pure Topical Antifungals: Dermatophytosis (Tinea corporis, Tinea cruris [dhobi itch], Tinea pedis), cutaneous candidiasis, pityriasis versicolor
- • Topical Antibacterials: Impetigo, folliculitis, infected eczema/wounds, nasal MRSA decolonisation (Mupirocin)
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: Co-indexed per approved Author Decisions DEC-03 (3A; from displaced HTML [12.27] & Inventory CSV mono-14-11) and DEC-12 (12A; from HTML [12.24]). Topical acne retinoid/peroxide and imidazole antifungals.
Administration & Meal Timing: External topical application only after washing and gently drying affected skin; wash hands before and after application (unless treating hands). Separate steroid cream and bland emollient by 20–30 minutes. | Once or twice daily after bathing and drying the skin thoroughly.
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Comparative pharmacokinetic profile co-indexed under [12.6].
Renal & Hepatic: No adjustment required for standard localised topical use. Caution: Applying >50 g/week of super-potent Clobetasol 0.05% over extensive denuded skin or under occlusion causes percutaneous systemic absorption, HPA-axis adrenal suppression, and iatrogenic Cushing's syndrome.
Renal & Hepatic: No adjustment required for standard localised topical use. Caution: Applying >50 g/week of super-potent Clobetasol 0.05% over extensive denuded skin or under occlusion causes percutaneous systemic absorption, HPA-axis adrenal suppression, and iatrogenic Cushing's syndrome.
Renal & Hepatic: No adjustment required for standard localised topical use. Caution: Applying >50 g/week of super-potent Clobetasol 0.05% over extensive denuded skin or under occlusion causes percutaneous systemic absorption, HPA-axis adrenal suppression, and iatrogenic Cushing's syndrome.
7. Contraindications, Precautions & High-Risk Warnings
- 1. THE EPIDEMIC INDIAN 'RINGWORM STEROID-COMBINATION' DISASTER (STRICT PHARMACIST BAN!): Across India, irrational fixed-dose triple/quadruple skin tubes combining a Super-Potent Steroid (Clobetasol) + Antifungal + Antibacterial (such as Panderm+, Quadriderm, Fourderm, Castor NF, Lobate-GM, Betnovate-C/N) are widely abused for fungal ringworm (Tinea cruris/corporis) and as fairness creams! Applying Clobetasol or Betnovate to a fungal infection suppresses local skin immunity—causing initial 2-day itch relief followed by explosive, treatment-resistant fungal spread ('Tinea Incognito'), irreversible purple skin striae (stretch marks), skin atrophy, telangiectasia, steroid rosacea, and HPA-axis Cushing's syndrome! NEVER dispense a steroid-containing cream for fungal ringworm, groin itch, acne, or facial fairness! 2. Never apply potent steroids (Clobetasol, Betamethasone) to the face, eyelids (causes glaucoma/cataracts!), axilla, or groin/genitalia!
Key Clinical Precautions: Renal & Hepatic: No adjustment required for standard localised topical use. Caution: Applying >50 g/week of super-potent Clobetasol 0.05% over extensive denuded skin or under occlusion causes percutaneous systemic absorption, HPA-axis adrenal suppression, and iatrogenic Cushing's syndrome.
8. Adverse Effects Profile
- Local transient stinging or burning; with prolonged/potent steroid misuse: skin thinning (epidermal atrophy), striae distensae, hypopigmentation, hypertrichosis, acneiform eruptions, perioral dermatitis.
- Systemic hypothalamic-pituitary-adrenal (HPA) axis suppression and iatrogenic Cushing's syndrome (when >50 g/week of Clobetasol 0.05% is applied over large body surfaces or under occlusion), glaucoma/cataracts (from periocular steroid use), recalcitrant steroid-modified dermatophytosis.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Minimal systemic drug interactions unless large-surface super-potent steroids are absorbed
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical parameters per parent class monograph [12.6].
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: 1. Enforce the '2-cm Margin & 2-Week Extra' Rule for Fungal Creams (Lulifin/Candid): Tell patients with groin/body ringworm to apply pure antifungal cream 2 cm beyond the red border and keep applying for 2 full weeks after the skin looks clear, while boiling/sun-drying cotton innerwear and avoiding tight damp clothes. 2. Demonstrate the Finger-Tip Unit (FTU) for steroid creams so patients apply a thin sheen rather than rubbing in half a tube. 3. If both a steroid cream and an emollient/moisturiser (liquid paraffin/white soft paraffin) are prescribed for eczema, wait 20–30 minutes between applying the steroid and the moisturiser. 4. For Permethrin 5% Cream (Perlice / Scabper for Scabies): Apply from the chin/jawline down to the soles of the feet (including webs between fingers/toes, wrists, navel, and groin), leave on overnight for 8 to 14 hours, wash off in the morning, treat all close family members simultaneously, wash bedsheets in hot water, and repeat a 2nd application exactly 7 days later! Explain that mild 'post-scabietic itching' can persist for 1–2 weeks after the mites are dead and does not mean treatment failed.
- Meal & Clock Timing Instruction: External topical application only after washing and gently drying affected skin; wash hands before and after application (unless treating hands). Separate steroid cream and bland emollient by 20–30 minutes. (Once or twice daily after bathing and drying the skin thoroughly.)
- Missed Dose Protocol: Apply as soon as remembered; do not apply double thickness.
- Geriatric Dispensing Pearl: Elderly CGHS patients have thin, fragile, xerotic (dry) senile skin with an impaired epidermal barrier—applying potent steroids (Tenovate/Betnovate) rapidly causes senile purpura, skin tearing, and ulceration. Encourage generous daily application of bland emollients (white soft paraffin + liquid paraffin) immediately after bathing while skin is damp.
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Creams (water-miscible base for weeping/acute/intertriginous lesions), Ointments (occlusive greasy base for dry, thick, lichenified plaques on palms/soles/extensors), Lotions/Solutions (for hairy scalp)
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacopoeia (IP 2022) • NFI • CDSCO
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [12.27] Povidone-Iodine (5% / 10% Antiseptic Solution, Ointment & Gargle) — Broad-Spectrum Iodophor Antiseptic & Disinfectant
- [12.28] Chlorhexidine Gluconate (0.2% Mouthwash & 4% Surgical Scrub) — Cationic Bisbiguanide Antiseptic & Disinfectant (Persistent Resid
- [12.29] Silver Sulfadiazine (1% Topical Burn Antimicrobial Cream) — Topical Heavy-Metal / Sulfonamide Burn Antimicrobial
- [12.6]-C153 Nadifloxacin — Topical Corticosteroids (Grouped by Potency: Super-Potent Clobeta